Lorcaserin Extended-Release Tablets and Topotecan Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Topotecan Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: topotecan
Brand name: Hycamtin
Synonyms: Topotecan (oral/injection), Topotecan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Topotecan oral/injection
- Lorcaserin Extended-Release Tablets-Toprol XL
- Lorcaserin Extended-Release Tablets-Topsyn
- Lorcaserin Extended-Release Tablets-Toradol
- Lorcaserin Extended-Release Tablets-Toradol (Ketorolac Injection)
- Lorcaserin Extended-Release Tablets-Toradol (Ketorolac Tablets)
- Topotecan Intravenous-Lorcaserin Hydrochloride
- Topotecan Intravenous-Lorcaserin Tablets
- Topotecan Intravenous-Lorcet
- Topotecan Intravenous-Lorcet Plus
- Topotecan Intravenous-Lorcet Tablets
- Topotecan Intravenous-Lorlatinib